The Institute of Cancer and Immunology (ICI) is presenting a blended mobility network on technical innovations in basic and translational research:applications to immunology-oncology (IO)

microscope et éprouvette

The Institute of Cancer and Immunology (ICI) offers to Master and PhD students the opportunity to follow a mixed international mobility program on the theme of "Technical innovations in basic and translational research: Applications to Immunology-Oncology (IO)" within the universities of the CIVIS alliance. Both virtual mobility in the form of e-learning (webinars and videos) and 5-days physical mobility in high-tech scientific platforms, will allow students to discover or to deepen their skills in Immuno-Oncology.

CANCER-IMMUNO-Bandeau-logos-Civis

 

First Institut Cancer et Immunologie Blended Mobility Program in Immunology-Oncology within CIVIS, the European Civic Universities.

Technical innovations in basic and translational research

Applications to Immunology-Oncology

June 2021 to June 2022, interdisciplinary, asynchronous and multi-campus

Program

The fundamental objective of the proposed program is to prepare future scientifists and medical doctors for the major evolutions of current concepts in the field of immuno-oncology by approaching the questions from a technical perspective. Thus, the teaching will be focused on technical applications in fundamental, translational and clinical immuno-oncology, through a blended mobility curriculum. The first component will be a virtual component with 5 courses as illustredin the following diagram.

CANCER-IMMUNO-logos1-page

The courses countain digital capsules of about 60 minutes each as fallow:

1) Cytometry (mass, flow and spectral)

  • Multi-color flow cytometry for phenotypic characterization of tumor-infiltrating T lymphocytes,Silvia Piconese, Sapienza Universita di Roma
  • Real-time cell analysis in immuno-oncology field,Mihaela EconomescuStefan S. Nicolau Institute of Virology, Bucharest Romania
  • Multi-parametric flow cytometry analysis for phenotypic characterization of aged-associated changes in circulating T cell subsets,Maria Mittelbrunn, Universidad Autonoma de Madrid
  • Evaluation of Neutrophils Functions in the Tumor Microenvironment,Luminita Marutescu, University of Bucharest
  • Cancer immunosurveillance - NK cells and cancer,Gratiela Gradisteanu, University of Bucharest
  • Detection of immune checkpoints and their ligands in tumor environment by multi-color flow cytometry,Lilia Matei, Stefan S. Nicolau Institute of Virology, Bucharest Romania
  • Evaluation of the immune function in tumors using multiplex xMAP technology,Coralia Bleotu, Stefan S. Nicolau Institute of Virology, Bucharest Romania
  • Multi-color imaging flow cytometry for characterization of cancer response to drug treatments,Cristina Elena Staicu, National Institute for Laser, Plasma and Radiation Physics, University of Bucharest ;Livia Elena Sima, Institute of Biochemistry of the Romanian Academy
  • Mass cytometry - Principles and applications,Amira A Ben Amara, Aix-Marseille Université
  • Spectral flow cytometry,Manon Richaud, Institut Paoli Calmettes, CRCM, Aix-Marseille Université
  • Computational methods for flow and mass cytometry data analysis,AS Chretien, Aix-Marseille Université

2) Organoids

  • Organoids: New biological models for research in developmental biology and cancer,Géraldine Guasch, CRCM, Aix-Marseille Université
  • Ex vivo culture of organoids for personalized medicine & regenerative medicine,Marie Isabelle Garcia, Université Libre de Bruxelles
  • 3D in vitro models of the human nervous system: challenges and opportunities,Alessandro Rosa, Sapienza Università di Roma
  • In vitro assessment of cellular energy metabolism and cell growth,Petronila Penela; Angela Albitre; Laura Formentini, Universidad Autónoma de Madrid
  • Animal Models for Tumor Immunology/Mouse Models for Cancer Immunotherapy Research,Catalina Ribas; Kostas Stamatakis; María Sanz, Universidad Autónoma de Madrid

3) Genomics (CRSPR, RNAseq and TCRseq)

  • Functional genomics using CRISPR Screening,Sandrine Roulland, Aix-Marseille Université
  • DNA microarrays and RNAseq in transcriptomics in cancer,Rodolfo Negri, Sapienza Università di Roma;Valerio Licursi, Sapienza Università di Roma
  • Single Cell RNA-seq (scRNAseq),Pierre Milpied, CIML, Aix-Marseille Université
  • TCR/CDR3 sequencing: insight into the development of T cells and their anti-cancer response,David Vermijlen Université Libre de Bruxelles

4) Proteomics

  • Protein analysis by mass spectrometry,Marco Crescenzi, Sapienza Università di Roma, Istituto Superiore di Sanità; Serena Camerini, Istituto Superiore di Sanità
  • Glycosylation characterization of IgG and its impact in cancer and immunology,Cédric Delporte; Arnaud Marchant, Université Libre de Bruxelles
  • Reverse Phase Protein Arrays: Identification of protein biomarkers of disease,José M. Cuezva, Universidad Autónoma de Madrid
  • Targeted proteomics: Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to her2-positive breast cancer,Luc Camoin, Aix-Marseille Université
  • Maldi imaging and therapeutic antibodies: application to glioma,Daniel Lafitte, Aix-Marseille Université

5) Microscopy-Imaging

  • Cryo-electron microscopy (Cryo-EM) for studying fine cellular structures and protein complexes in immune cells and cancer cells, Luciana Dini, Sapienza Università di Roma
  • 3D structured illumination microscopy for studies on nuclear integrity and cancer invasion,Isabella Saggio, Sapienza Universita di Roma
  • Intravital imaging in the zebrafish model for new insights into the roles of microglia in physiology and disease,Valérie Wittamer, Université Libre de Bruxelles
  • Spatio-temporal organization of macromolecular complexes involved in lymphocyte signaling,Didier Marguet, CIML, Aix-Marseille Université
  • Isolation and characterization techniques for the study of exosomes,María Yáñez-Mó, Universidad Autónoma de MadridMar Valés-Gómez; Noa Martín Cofreces

Students will receive the technical theoretical bases enabling them to understand the functioning of these innovative technologies, as well as the applications to the exploration of anti-tumor immunity in aspects ranging from the fundamental research to the clinical approaches. The critical step of data analysis using machine learning algorithms will also be addressed in the different themes.

The second component will be a short-term mobility exchange of 5 days within the scientific platforms of the CIVIS immunology-oncology network as illustrated in the following diagram.

CANCER-IMMUNO-logos2-page

This component will allow students to practically experience what was learned in the virtual component. Based on a detailed application form, they will be oriented to a platform that matches their selection parameters. We do not anticipate any flow problems (e.g. students not being able to find platforms) as there are a diversity of platforms with overlapping technology.

Registration

Application here

Useful information

Virtual Mobility

Coming soon !

Physical Mobility

Organizing Committee

  • Anne-Sophie Chrétien, Aix-Marseille Université (AMU), Institut Paoli Calmettes (IPC), Institut Cancer et Immunology (ICI), Faculté de Médecine de Marseille, Centre de Recherche en Cancérologie de Marseille (CRCM)
  • Marie-dominique Franco, Project Manager, Institute of Cancer and Immunology (ICI, AMU)
  • Luminita Marutescu, University of Bucharest, Faculty of Biology, Department of Biotechnology and Renewable Resources, Research Platform in Biology and Systems Ecology
  • Catalinai Ribas and María Yánez Mo Universidad Autonoma de Madrid, Faculty of Sciences, Department of Molecular Biology
  • Loretta Tuosto, Sapienza Università di Roma, Faculty of Mathematical, Physical and Natural Sciences, Department of Biology and Biotechnology Charles Darwin (BBCD)
  • David Vermijlen, Université Libre de Bruxelles, Pharmacy Faculty, Department of Pharmacotherapy and Pharmaceutics and UBL Center for Research in Immunology

About CIVIS

CIVIS is a European civic university formed by the alliance of nine of Europe's leading higher education research institutions: Aix-Marseille Université, National and Kapodistrian University of Athens, Universitatea din București, Université Libre de Bruxelles, Universidad Autónoma de Madrid, Sapienza Università di Roma, Stockholm University, Eberhard Karls Universität Tübingen and the University of Glasgow.

It brings together a community of over 384,000 students and 55,000 staff, including 30,000 academics and researchers.

Partner universities of the 1st international mobility programme with Aix-Marseille Université :

Useful links
Registration form

INTERNATIONAL KEYNOTE SPEAKERS

  • Module Cytometry (mass, flow and spectral) Roberto Spada Fluidigm, Spain
  • Module Organoids and in vivo models Maxime Mahé, University of Nantes, France Federico Mayor Universidad Autonoma de Madrid, Spain
  • Module Genomics (CRISPR, RNAseq, scRNAseq and TCR Seq)
  • Module Proteomics Isabelle Fournier University of Lille, France
  • Module Microscopy-imaging Francisco Sanchez-Madrid, Universidad Autonoma de Madrid, Spain
Contact information
Keywords
Institute of Cancer and Immunology, HERE
Student Mobility, Master, PhD
CIVIS
Cancerology, Cancer, Immunology, Immuno-Oncology
Translational Fundamental Clinical Research
Cytometry, Organoids, Genomics, Proteomics, Microscopy-Imaging